| Theodore Young Kim, M.D., F.A.C.G. |
|
| Education: |
| University of Maryland; B.S., 1980 |
| University of Maryland School of Medicine; M.D., 1984 |
| Kaiser Permanente Medical Center, San Francisco, CA; Internship,
1984-1985 |
| Kaiser Permanente Medical Center, San Francisco, CA; residency,
1985-1986 |
| University of Maryland Hospital, Baltimore, MD; Residency,
1986-1987 |
| UMDNJ- New Jersey (GI) 1988-1990 |
| Certification: |
1985 National Board of Medical Examiners
1987 Diplomat, American Board of Internal Medicine
1987-1989 ACLS
1987-1991 ATLS
1991 Diplomat, ABIM, Gastroenterology
2001 Recertification, Diplomat, American Board of Internal Medicine |
| Professional Membership: |
American Medical Association
American College of Physicians
American Medical Student Association
American Gastroenterological Association
American College of Gastroenterology
American Society for Gastrointestinal Endoscopy |
Research Facility: |
Maryland Digestive Disease Research LLC, Co-Owner
7350 Van Dusen Road Suite 360
Laurel, MD 20707
Investigator 1997- present |
Research Trials: |
Principal Investigator
2002 12-week Randomized, Double- Blind, Placebo- Controlled,
Fixed-Dose, Parallel Group, Multicenter, Study of the Safety
and Efficacy of XXX 200 Mg B.I.D. 200 Mg B.I.D. and 200 Mg
T.I.D. in Female Patients with Constipation-Predominant Irritable
Bowel Syndrome
2002 An Open-Label Extension of Study XXX to investigate
the Long- Term Safety and Efficacy of XXX 200 Mg T.I.D. in
Female Patients with Constipation-Predominant Irritable Bowel
Syndrome
2001 A Multi-center Double-Blind, Randomized Study to compare
the safety and Efficacy of XXX Extended Release (ER) 150 mg
twice daily (BID), XXX ER 300 mg (QD) and Placebo in the treatment
of subjects with symptomatic, Endoscopically Confirmed Erosive
Gastroesophagael Reflux Disease (GERD) |
| Sub-Investigator |
| A Randomized, Placebo-Controlled Trial of XXX for treatment
of Ulcerative Colitis |
| Dose Comparison Study of XXX + XXX for Patients with Chronic
Hepatitis C Who Have Not Responded to Standard XXX + XXX |
| A Comparative Efficacy and Safety Study of XXX Delayed-Release
Capsules Versus Placebo for the prevention of Gastric Ulcers
Associated with daily NSAID Use in Patients at risk |
| Endoscopic Study of Gastro duodenal Effects in patients in
patients with Rheumatoid Arthritis |
| Research Projects: |
| Enzymatic Sulfation of Glycoprotein Mucus in Health and Gastric
Diseases. |
| Hepatic Vein Catherization and Response to Portal Pressures
to Propanol. |
| Hospital Affiliations: |
Laurel Regional Hospital:
Chief of Gastroenterology 1995- Present
Medical Executive Committee 1996- Present |
| Washington Adventist Hospital |
| Howard County General Hospital |
Emergency Room Attending (7/87-6/88)
Prince George’s Hospital Center, Level I Trauma Center
Department of Emergency Medicine
One Hospital Drive
Cheverly, Maryland 20785 |
| Other: |
Maryland Digestive Disease Center
7350 Van Dusen Rd. Suite 210
Laurel, MD 20707 |
Ambulatory Endoscopy Center of Maryland
7350 Van Dusen Rd. 230
Laurel, MD 20707 |
| |
